🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Corticosteroids, intravenous immunoglobulin (IVIG), and plasma exchange (PE...
Status
Completed
Location
Xuanwu Hospital of Capital Medical University
Start Date
2020-11-25
Trial ID
NCT03542279
The trial tests the hypothesis that, in adults with active, moderate-to-sev...
Status
Not Yet Recruiting
Location
Universitas Gadjah Mada
Start Date
2026-08-30
Trial ID
NCT07762105
Treatments Being Tested
This study is aimed to observe the effectiveness and safety of inebilizumab...
Status
Unknown
Location
Xuanwu Hospital, Capital Medical University
Start Date
2024-07-09
Trial ID
NCT05891379
Treatments Being Tested
To investigate the efficacy，safety and tolerability of 99Tc-MDP in comparis...
Status
Completed
Location
Affiliated Zhongshan Hospital of Dalian University
Start Date
2017-10-16
Trial ID
NCT03948191
Treatments Being Tested
Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, inflammatory...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-09-03
Trial ID
NCT06673394
Treatments Being Tested
The alterations of coagulation and fibrinolysis parameters have been descri...
Status
Completed
Location
Multiple Locations
Start Date
2011-01-01
Trial ID
NCT03535090
Treatments Being Tested
This study aims to evaluate the efficacy and safety of sequential Teprotumu...
Status
Not Yet Recruiting
Location
Zhongshan Ophthalmic Center, Sun Yat-sen University
Start Date
2026-08
Trial ID
NCT07594912
Treatments Being Tested
Although ACTHAR gel is approved for the treatment of acute relapses, it is ...
Status
Unknown
Location
Icahn School of Medicine at Mount Sinai
Start Date
2013-07
Trial ID
NCT01900093
Treatments Being Tested
To compare the safety and efficacy of Inebilizumab and Rituximab in neuromy...
Status
Unknown
Location
Multiple Locations
Start Date
2023-10-20
Trial ID
NCT06068829
Treatments Being Tested
NMOSD is an autoimmune disease of the central nervous system that predomina...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-05
Trial ID
NCT06497374
Treatments Being Tested